BR0312141A - Pastas veterinárias homogêneas orais anti-helmìnticas - Google Patents
Pastas veterinárias homogêneas orais anti-helmìnticasInfo
- Publication number
- BR0312141A BR0312141A BR0312141-0A BR0312141A BR0312141A BR 0312141 A BR0312141 A BR 0312141A BR 0312141 A BR0312141 A BR 0312141A BR 0312141 A BR0312141 A BR 0312141A
- Authority
- BR
- Brazil
- Prior art keywords
- anthelmintic
- pastes
- oral
- veterinary
- homogeneous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"PASTAS VETERINáRIAS HOMOGêNEAS ORAIS ANTI-HELMìNTICAS". A presente invenção refere-se a, entre outras coisas, pastas veterinárias homogêneas orais para o tratamento, controle e prevenção de infecções endo e ectoparasíticas em animais de sangue quente ou pássaros, tais como cavalos e animais domésticos. Esta invenção também refere-se a um processo de preparar estas pastas veterinárias e um método para aumentar a biodisponibilidade dos agentes anti-helmínticos contidos na pasta no animal de sangue quente ou pássaro. As pastas anti-helmínticas homogêneas orais inventivas compreendem um primeiro agente anti-helmíntico, por exemplo, praziquantel e/ou pirantel, e pelo menos um composto anti-helmíntico de macrolídeo, um solvente que dissolve igualmente o primeiro agente anti-helmíntico e o segundo composto anti-helmíntico de macrolídeo, e um agente espessante. As pastas homogêneas orais inventivas obtêm uma melhor disponibilidade dos dois agentes anti-helmínticos ativos do que quando os dois ativos estão em uma suspensão e não dissolvidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/177,822 US7001889B2 (en) | 2002-06-21 | 2002-06-21 | Anthelmintic oral homogeneous veterinary pastes |
PCT/US2003/019025 WO2004000034A2 (en) | 2002-06-21 | 2003-06-13 | Anthelmintic oral homogeneous veterinary pastes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0312141A true BR0312141A (pt) | 2005-06-28 |
Family
ID=29734505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0312141-0A BR0312141A (pt) | 2002-06-21 | 2003-06-13 | Pastas veterinárias homogêneas orais anti-helmìnticas |
Country Status (20)
Country | Link |
---|---|
US (2) | US7001889B2 (pt) |
EP (1) | EP1534072B1 (pt) |
JP (1) | JP4342440B2 (pt) |
AR (1) | AR039722A1 (pt) |
AT (1) | ATE390123T1 (pt) |
AU (1) | AU2009200336B2 (pt) |
BR (1) | BR0312141A (pt) |
CA (1) | CA2490309C (pt) |
CY (1) | CY1108533T1 (pt) |
DE (1) | DE60319996T2 (pt) |
DK (1) | DK1534072T3 (pt) |
ES (1) | ES2306879T3 (pt) |
MA (1) | MA27313A1 (pt) |
MX (1) | MXPA05000172A (pt) |
NZ (2) | NZ555185A (pt) |
PT (1) | PT1534072E (pt) |
SI (1) | SI1534072T1 (pt) |
TN (1) | TNSN04258A1 (pt) |
WO (1) | WO2004000034A2 (pt) |
ZA (1) | ZA200410250B (pt) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893652B2 (en) * | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
HUE032009T2 (en) * | 2003-04-04 | 2017-09-28 | Merial Inc | Veterinary preparations for topical veterinary use |
US7049076B2 (en) * | 2003-07-09 | 2006-05-23 | Sentigen Biosciences, Inc. | Method for assaying protein—protein interaction |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
SI1566173T1 (sl) * | 2004-02-20 | 2006-12-31 | Mattern Udo | Farmacevtska zmes za oralno aplikacijo in postopek njene priprave |
US7582612B2 (en) * | 2004-03-12 | 2009-09-01 | Hartz Mountain Corporation | Multi-action anthelmintic formulations |
ES2383193T3 (es) * | 2004-09-09 | 2012-06-19 | Warburton Technology Limited | Elementos traza |
DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
AU2006203347C1 (en) * | 2006-05-15 | 2009-11-05 | Wyeth | Stabilised formulation |
EP2465851A1 (en) | 2006-07-05 | 2012-06-20 | Aventis Agriculture | 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
NZ550279A (en) * | 2006-09-29 | 2008-01-31 | Bomac Research Ltd | Medicament |
RS58416B1 (sr) | 2007-05-15 | 2019-04-30 | Merial Inc | Ariloazol-2-il cijanoetilamino jedinjenja, postupci dobijanja i postupci njihove primene |
EP2214656B1 (en) | 2007-10-26 | 2018-12-05 | Avivagen Inc. | Compositions and methods for enhancing immune response |
JP5319691B2 (ja) * | 2007-11-15 | 2013-10-16 | ノバルティス アーゲー | プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト |
US20100022469A1 (en) * | 2008-06-24 | 2010-01-28 | Majid Razzak | Anthelminthic formulations |
MX2011001789A (es) * | 2008-08-20 | 2011-05-30 | Futurefuel Chemical Co | Proceso para la preparacion de glicerol-formal. |
MX2009001235A (es) * | 2008-09-19 | 2010-04-29 | Agrovet Market S A | Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina. |
AU2009313920B2 (en) | 2008-11-14 | 2014-10-23 | Boehringer Ingelheim Animal Health USA Inc. | Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds |
WO2010059529A2 (en) | 2008-11-19 | 2010-05-27 | Merial Limited | Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof |
TWI457347B (zh) | 2008-12-04 | 2014-10-21 | Merial Ltd | 二聚合的阿佛菌素(avermectin)及密倍脈心(milbemycin)衍生物 |
WO2010124391A1 (en) | 2009-04-30 | 2010-11-04 | Chemaphor Inc. | Methods and compositions for improving the health of animals |
TW201041508A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
MX2012001170A (es) | 2009-07-30 | 2012-07-20 | Merial Ltd | Compuestos de 4-amino-tieno [2,3-d]pirimidina insecticidas y metodos para su uso. |
MX2012006366A (es) | 2009-12-04 | 2012-06-27 | Basf Se | Compuesto de bis-organoazufre plaguicidas. |
EP2512467A1 (en) | 2009-12-17 | 2012-10-24 | Merial Limited | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
EA201401222A1 (ru) | 2009-12-17 | 2015-10-30 | Мериал Лимитед | Противопаразитарные дигидроазоловые соединения и содержащие их композиции |
UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
NZ610547A (en) | 2010-11-16 | 2015-07-31 | Merial Ltd | Novel monensin derivatives for the treatment and prevention of protozoal infections |
AU2012275435B2 (en) | 2011-06-27 | 2016-07-21 | Boehringer Ingelheim Animal Health USA Inc. | Amido-pyridyl ether compounds and compositions and their use against parasites |
US20120329832A1 (en) | 2011-06-27 | 2012-12-27 | Jean Delaveau | Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use |
CA2855954C (en) | 2011-11-17 | 2020-09-01 | Merial Limited | Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof. |
EP2594258B1 (en) | 2011-11-18 | 2020-03-18 | Veterinärmedizinische Universität Wien | Oral gel comprising praziquantel |
BR112014013371B1 (pt) | 2011-12-02 | 2020-04-07 | Merial Ltd | formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina |
JP6273252B2 (ja) * | 2012-03-13 | 2018-01-31 | バイエル・ニュージーランド・リミテッド | 長時間作用型の組成物 |
EP2922845B1 (en) | 2012-11-20 | 2018-06-20 | Merial, Inc. | Anthelmintic compounds and compositions and method of using thereof |
WO2015064680A1 (ja) * | 2013-10-30 | 2015-05-07 | 大蔵製薬株式会社 | 服用し易いゼリー状医薬組成物 |
CN105873925B (zh) | 2013-11-01 | 2019-09-10 | 勃林格殷格翰动物保健美国公司 | 抗寄生物的和杀虫的异噁唑啉化合物 |
ES2842592T3 (es) | 2014-05-19 | 2021-07-14 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos antihelmínticos |
WO2016054373A1 (en) * | 2014-10-01 | 2016-04-07 | Merial Inc. | Dissolution testing of hydrophobic active pharmaceutical ingredients such as avermectins with or without pyrantel |
ES2916216T3 (es) | 2015-05-20 | 2022-06-29 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de depsipéptidos antihelmínticos |
UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
US10137111B2 (en) | 2016-08-11 | 2018-11-27 | Adamis Pharmaceuticals Corporation | Drug compositions comprising an anti-parasitic and proton pump inhibitor |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
AU2017344097A1 (en) | 2016-10-14 | 2019-05-02 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal vinyl isoxazoline compounds |
EP3541789A1 (en) | 2016-11-16 | 2019-09-25 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic depsipeptide compounds |
JP2020530850A (ja) | 2017-08-14 | 2020-10-29 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 殺有害生物および殺寄生生物ピラゾール−イソキサゾリン化合物 |
RU2681214C1 (ru) * | 2017-10-12 | 2019-03-05 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук | Способ получения средства для лечения однокопытных животных при паразитозах |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
US11583545B2 (en) | 2018-02-08 | 2023-02-21 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof |
EP3820870A1 (en) | 2018-07-09 | 2021-05-19 | Boehringer Ingelheim Animal Health USA Inc. | Anthelminthic heterocyclic compounds |
US11773066B2 (en) | 2018-11-20 | 2023-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof |
PE20220281A1 (es) | 2019-03-19 | 2022-02-25 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos |
JP2023528822A (ja) | 2020-05-29 | 2023-07-06 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性複素環式化合物 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3502661A (en) | 1967-02-14 | 1970-03-24 | Pfizer & Co C | Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines |
US4001441A (en) | 1970-12-21 | 1977-01-04 | The Procter & Gamble Company | Meat analog |
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
US4196291A (en) | 1973-12-17 | 1980-04-01 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof |
IN142490B (pt) | 1974-05-15 | 1977-07-16 | Bayer Ag | |
US4032655A (en) | 1974-05-15 | 1977-06-28 | Bayer Aktiengesellschaft | Phenylguanidines useful as anthelmintic agents |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US5089490A (en) | 1977-04-02 | 1992-02-18 | Hoechst Aktiengesellschaft | Cephem derivatives |
US4197307A (en) | 1977-04-12 | 1980-04-08 | Ciba-Geigy Corporation | 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
PH15982A (en) | 1977-10-03 | 1983-05-18 | Merck & Co Inc | Selective hydrogenation producta of c-076 compounds and derivatives thereof |
NZ188459A (en) | 1977-10-03 | 1982-09-07 | Merck & Co Inc | Derivatives of c-076 compounds and pesticidal compositions |
US4200581A (en) | 1978-08-04 | 1980-04-29 | Merck & Co., Inc. | Alkyl derivatives of C-076 compounds |
EP0021758B1 (en) | 1979-06-27 | 1984-04-04 | Beecham Group Plc | Veterinary preparations for ruminant animals |
JPS57139012A (en) | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4427663A (en) | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
US4633372A (en) | 1985-08-26 | 1986-12-30 | The Standard Oil Company | Polyoxometalate-modified carbon electrodes and uses therefor in capacitors |
EP0237482A1 (de) | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen |
AR243191A1 (es) | 1986-03-25 | 1993-07-30 | Sankyo Co | Procedimiento para preparar compuestos de macrolida |
ATE75745T1 (de) | 1986-07-02 | 1992-05-15 | Ciba Geigy Ag | Pestizide. |
US4855317A (en) | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
US4871719A (en) | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
US4874749A (en) | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
DE3888936T2 (de) | 1987-11-03 | 1994-07-21 | Beecham Group Plc | Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung. |
NZ232422A (en) | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
JP2893901B2 (ja) | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
JP3182229B2 (ja) | 1992-09-17 | 2001-07-03 | 大日本製薬株式会社 | 動物用懸濁型ペースト剤 |
US5345377A (en) | 1992-10-30 | 1994-09-06 | Electric Power Research Institute, Inc. | Harmonic controller for an active power line conditioner |
IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
DE19520275A1 (de) | 1995-06-02 | 1996-12-05 | Bayer Ag | Endoparasitizide Mittel |
EP0959891A1 (en) * | 1996-07-30 | 1999-12-01 | Ashmont Holdings Limited | Anthelmintic formulations |
IL126741A0 (en) | 1998-10-25 | 1999-08-17 | Yam Daniel | Solidification of fluid oils and their use |
NZ336832A (en) | 1999-07-21 | 2000-10-27 | Ancare New Zealand Ltd | Anthelmintic formulation comprising praziquantel, a macrolide, a preservative, buffer salts, defoaming agent, dispersing agent and water |
US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
US6340672B1 (en) | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
US6207179B1 (en) | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
-
2002
- 2002-06-21 US US10/177,822 patent/US7001889B2/en not_active Expired - Lifetime
-
2003
- 2003-06-13 AT AT03737140T patent/ATE390123T1/de active
- 2003-06-13 ES ES03737140T patent/ES2306879T3/es not_active Expired - Lifetime
- 2003-06-13 JP JP2004515836A patent/JP4342440B2/ja not_active Expired - Lifetime
- 2003-06-13 DK DK03737140T patent/DK1534072T3/da active
- 2003-06-13 CA CA2490309A patent/CA2490309C/en not_active Expired - Lifetime
- 2003-06-13 EP EP03737140A patent/EP1534072B1/en not_active Expired - Lifetime
- 2003-06-13 WO PCT/US2003/019025 patent/WO2004000034A2/en active Application Filing
- 2003-06-13 SI SI200331229T patent/SI1534072T1/sl unknown
- 2003-06-13 PT PT03737140T patent/PT1534072E/pt unknown
- 2003-06-13 MX MXPA05000172A patent/MXPA05000172A/es active IP Right Grant
- 2003-06-13 NZ NZ555185A patent/NZ555185A/en not_active IP Right Cessation
- 2003-06-13 DE DE60319996T patent/DE60319996T2/de not_active Expired - Lifetime
- 2003-06-13 BR BR0312141-0A patent/BR0312141A/pt not_active Application Discontinuation
- 2003-06-13 NZ NZ537407A patent/NZ537407A/en not_active IP Right Cessation
- 2003-06-20 AR ARP030102207A patent/AR039722A1/es not_active Application Discontinuation
-
2004
- 2004-12-20 ZA ZA2004/10250A patent/ZA200410250B/en unknown
- 2004-12-21 TN TNP2004000258A patent/TNSN04258A1/en unknown
- 2004-12-30 MA MA28026A patent/MA27313A1/fr unknown
-
2005
- 2005-04-15 US US11/107,048 patent/US7563773B2/en not_active Expired - Lifetime
-
2008
- 2008-06-24 CY CY20081100661T patent/CY1108533T1/el unknown
-
2009
- 2009-01-30 AU AU2009200336A patent/AU2009200336B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NZ537407A (en) | 2007-07-27 |
WO2004000034A2 (en) | 2003-12-31 |
US20030236203A1 (en) | 2003-12-25 |
AU2009200336B2 (en) | 2011-09-15 |
MA27313A1 (fr) | 2005-05-02 |
AU2009200336A1 (en) | 2009-02-19 |
JP2005533806A (ja) | 2005-11-10 |
CA2490309A1 (en) | 2003-12-31 |
ATE390123T1 (de) | 2008-04-15 |
US20050176657A1 (en) | 2005-08-11 |
CA2490309C (en) | 2011-09-27 |
SI1534072T1 (sl) | 2008-10-31 |
MXPA05000172A (es) | 2005-06-03 |
DE60319996T2 (de) | 2009-05-20 |
DK1534072T3 (da) | 2008-07-14 |
TNSN04258A1 (en) | 2007-03-12 |
EP1534072A4 (en) | 2005-10-26 |
WO2004000034A3 (en) | 2004-02-26 |
AR039722A1 (es) | 2005-03-09 |
DE60319996D1 (de) | 2008-05-08 |
JP4342440B2 (ja) | 2009-10-14 |
EP1534072B1 (en) | 2008-03-26 |
US7563773B2 (en) | 2009-07-21 |
EP1534072A2 (en) | 2005-06-01 |
US7001889B2 (en) | 2006-02-21 |
ZA200410250B (en) | 2005-11-30 |
NZ555185A (en) | 2009-04-30 |
AU2003238245A1 (en) | 2004-01-06 |
PT1534072E (pt) | 2008-06-03 |
CY1108533T1 (el) | 2014-04-09 |
ES2306879T3 (es) | 2008-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312141A (pt) | Pastas veterinárias homogêneas orais anti-helmìnticas | |
BRPI0412527A (pt) | composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto. | |
BR0013010B1 (pt) | Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina | |
BRPI0611747A2 (pt) | composto ou um sal farmaceuticamente aceitÁvel do mesmo ou n-àxidos do mesmo, composiÇço farmacÊutica, mÉtodos para tratar uma infecÇço bacteriana e para inibir o dna girase bacteriana em um animal de sangue quente, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, e, processo para fabricar um composto ou um sal farmaceuticamente aceitÁvel do mesmo | |
AR035039A1 (es) | COMPOSICIONES QUE COMPRENDEN COMPONENTES TERAPEeTICAMENTE ACTIVOS DE SOLUBILIDAD Y BIODISPONIBILIDAD INCREMENTADA | |
BR0313160A (pt) | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto | |
BRPI0519135A2 (pt) | macrolÍdeos | |
BR0209271A (pt) | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto | |
EA200000594A1 (ru) | Новые макролиды | |
BRPI0417958A (pt) | composto, composição farmacêutica, processo para a preparação de um sal maleato, uso de um sal maleato, e, método para produzir um efeito redutor na permeabilidade antiangiogênica e/ou vascular em um animal de sangue quente | |
CY1116180T1 (el) | Συνθεσεις ομογενους παστας | |
ATE358474T1 (de) | Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung | |
ES2183359T3 (es) | Agente desinfectante de pezones por inmersion. | |
BR8001094A (pt) | Derivado de acido quinolinocarboxilico e seu sal, processo para preparar tal derivado, agente antimicrobiano, bem como processos para prevenir ou tratar uma doenca de animais, para esterilizacao de equipamento e instrumentos medicinais e outros e para controlar danos em plantas | |
BR0316187A (pt) | Formulações parasiticidas tópicas e métodos de tratamento | |
BR9916190A (pt) | Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas | |
BRPI0510694A (pt) | composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole | |
BR0016430A (pt) | Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica | |
BRPI0408846A (pt) | compostos para o tratamento de infecções por flaviviridae | |
CO6491066A2 (es) | Metodo quimico para esterilizacion sexual y eliminacion de libido en mamiferos machos | |
BRPI0407271A (pt) | Composição anti-helmìntica | |
Kumar et al. | Comparative curative efficacy of ivermectin and ivermectin with vitamin supplementation treatment against naturally infested Sarcoptes scabiei Mite in rabbits: a retrospective study | |
MX2009006656A (es) | Formulaciones homogeneas en pasta y gel. | |
Arora et al. | Therapeutic management of chronic generalized demodicosis in a pug | |
TR200003588T2 (tr) | Biyolojik olarak aktif bileşim |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25C | Requirement related to requested transfer of rights |
Owner name: MERIAL LTD. (US) |
|
B25A | Requested transfer of rights approved |
Owner name: MERIAL, INC (US) |